Status:
NOT_YET_RECRUITING
Nebulized 3% Hypertonic Saline Versus Normal Saline in Managing Children With Acute Bronchiolitis: A Randomized Controlled Trial
Lead Sponsor:
University Of Anbar
Conditions:
Acute Bronchiolitis
Eligibility:
All Genders
Up to 24 years
Phase:
NA
Brief Summary
This randomized controlled trial was conducted at A-Ramadi Teaching Hospital for Maternity and Children on patients admitted with acute bronchiolitis. The study covered a duration of 6 months. The stu...
Detailed Description
Introduction Bronchiolitis is an acute viral infection of the lower respiratory tract, most commonly caused by the respiratory syncytial virus (RSV). By the age of one year, more than 60% of children ...
Eligibility Criteria
Inclusion
- All patients aged 0-24 months with a clinical diagnosis of bronchiolitis, defined by signs of acute respiratory distress, chest radiographic findings consistent with bronchiolitis, and a bronchiolitis severity score of (2-3), whose parents or guardians provided informed consent were enrolled in the study.
- \-
Exclusion
- Exclusion criteria were: severely ill infants requiring mechanical ventilation; age greater than 2 years; presence of chronic illnesses such as chronic renal disease, congenital heart disease, or neuromuscular disorders; immunocompromised status (including malnutrition or chronic corticosteroid use); diagnosis of asthma; prior use of corticosteroids or bronchodilators; and refusal of caregivers to participate in the trial.
- \-
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07138625
Start Date
October 1 2025
End Date
March 31 2026
Last Update
August 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.